Ticker Details
GeneDx Holdings Corp.
IPO Date:	November 2, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$2.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.04 | 4.78%
Avg Daily Range (30 D):	$2.57 | 3.74%
Avg Daily Range (90 D):	$2.58 | 4.32%

Institutional Daily Volume
Avg Daily Volume:	.81M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	42
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	1,315
Avg Institutional Trade:	$3.42M
Avg Institutional Trade (30 D):	$4.3M
Avg Institutional Trade (90 D):	$3.42M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.1M
Avg Closing Trade (30 D):	$5.6M
Avg Closing Trade (90 D):	$5.65M
Avg Closing Volume:	66.72K

News

Aug 1, 2026 @ 3:27 PM WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNS... Source: Rosen Law Firm

Aug 1, 2026 @ 7:16 AM מועד אחרון לת... Source: Rosen Law Firm

Jul 31, 2026 @ 10:55 AM MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Inves... Source: Robbins Geller Rudman & Dowd Llp

Jul 30, 2026 @ 3:48 PM GeneDx Shareholder Alert: ClaimsFiler Reminds Inve... Source: Claimsfiler

Jul 30, 2026 @ 2:30 AM WGS DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR ... Source: Rosen Law Firm

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.6	$-2.16	$-.61
Diluted EPS	$-.6	$-2.16	$-.61
Revenue	$114.44M	$102.25M	$120.99M
Gross Profit	$78.24M	$68.21M	$84.27M
Net Income / Loss	$-17.74M	$-63.32M	$-17.67M
Operating Income / Loss	$-17.46M	$-57.47M	$-14.24M
Cost of Revenue	$36.2M	$34.04M	$36.72M
Net Cash Flow	$-33.61M	$-11.07M	$9.03M
PE Ratio

Splits
May 04, 2023	1:33